Drug-eluting beads versus conventional chemoembolization for the treatment of unresectable hepatocellular carcinoma-Reference-Cited by-同舟云学术

Drug-eluting beads versus conventional chemoembolization for the treatment of unresectable hepatocellular carcinoma

Published:2016-02-26 Issue:3 Volume:31 Page:645-653
ISSN:0815-9319
Container-title:Journal of Gastroenterology and Hepatology
language:en
Short-container-title:Journal of Gastroenterology and Hepatology

Author:

Facciorusso Antonio¹,Mariani Luigi²,Sposito Carlo¹,Spreafico Carlo³,Bongini Marco¹,Morosi Carlo³,Cascella Tommaso³,Marchianò Alfonso³,Camerini Tiziana²,Bhoori Sherrie¹,Brunero Federica²,Barone Michele⁴,Mazzaferro Vincenzo¹

Affiliation:

1. Gastroenterology, Surgery and Liver Transplantation Unit; Fondazione Istituto Nazionale Tumori IRCCS-National Cancer Institute; Milan Italy

2. Trial Office and Biomedical Statistics; Fondazione Istituto Nazionale Tumori IRCCS-National Cancer Institute; Milan Italy

3. Department of Interventional Radiology; Fondazione Istituto Nazionale Tumori IRCCS-National Cancer Institute; Milan Italy

4. Department of Gastroenterology; University of Bari; Bari Italy

Funder

National Cancer Institute institutional grants on Hepato-Oncology

Italian Association for Cancer Research

Publisher

Wiley

Subject

Gastroenterology,Hepatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/jgh.13147/fullpdf

Reference19 articles.

1. Hepatocellular carcinoma;El-Serag;N. Engl. J. Med.,2011

2. European Association for the Study of the Liver and European Organisation for Research and Treatment of Cancer. EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma;J. Hepatol.,2012

3. Practice guidelines committee, american association for the study of liver disease. Management of hepatocellular carcinoma. An update;Bruix;Hepatology,2011

4. Evolving strategies for the management of intermediate-stage hepatocellular carcinoma: available evidence and expert opinion on the use of transarterial chemoembolization;Raoul;Cancer Treat. Rev.,2011

5. Chemoembolization of hepatocellular carcinoma with drug eluting beads: efficacy and doxorubicin pharmacokinetics;Varela;J. Hepatol.,2007

Cited by 75 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. DEB‐TACE versus cTACE for unresectable HCC with B1‐type bile duct invasion after successful biliary drainage: A propensity score matching analysis;Cancer Medicine;2024-07

2. Trans-Arterial Chemoembolization or Bland Embolization for the Treatment of Hepatocellular Carcinoma: A Propensity Score Analysis;2024-06-18

3. Drug-Eluting Bead Transarterial Chemoembolization for Hepatocellular Carcinoma: The Effectiveness of Different Particle Sizes in Downstaging and Bridging in Living Donor Liver Transplantation;Transplantation Proceedings;2024-04

4. Efficacy and safety of drug-eluting bead transarterial chemoembolization (DEB-TACE) combined with tyrosine kinase inhibitors (TKIs) in patients with unresectable hepatocellular carcinoma (uHCC): A systematic review and meta-analysis;Clinics and Research in Hepatology and Gastroenterology;2024-04

5. S3-Leitlinie „Diagnostik und Therapie biliärer Karzinome“ – Kurzversion;Zeitschrift für Gastroenterologie;2024-02